ERLANGER BLEDSOE HOSPITAL — History
CCN 441306 | 3-year financial timeline | COVID resilience: 34/100
🛡️ Public data only — no PHI permitted on this instance.
$17M
Latest Revenue (FY2022)
+0.9%
Revenue CAGR (3yr)
-0.9%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $17M | $19M | $17M | -11.5% | +0.9% |
| Operating Expenses | $15M | $16M | $17M | +8.0% | +6.6% |
| Operating Margin | 9.5% | 17.4% | -0.9% | -104.9% | +0.0% |
| Net Income | $2M | $3M | $-0M | -104.4% | +0.0% |
| Licensed Beds | 25 | 25 | 25 | +0.0% | +0.0% |
| Total Patient Days | 1,639 | 1,901 | 1,573 | -17.3% | -2.0% |
| Medicare Day % | 70% | 51% | 59% | +15.1% | -8.1% |
| Medicaid Day % | 21% | 0% | 0% | -86.6% | -94.5% |
COVID Impact & Recovery
Resilience Score: 34/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: +1.9% ($17M → $17M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▶ Stable
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+0.9%
This Hospital
+7.6%
State Avg
Latest Margin
-0.9%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $17M | -6.0% |
| FY2024 (proj) | $17M | -11.2% |
| FY2025 (proj) | $17M | -16.3% |